Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai X-Tal Biomedical Technology is a biotechnology company specializing in structure-based drug discovery (SBDD) and high-resolution protein crystallography. The company leverages its core expertise in structural biology to facilitate the design and optimization of novel small molecule therapeutics for challenging biological targets. X-Tal provides a comprehensive suite of services, including protein expression, purification, and X-ray crystallography, to support both internal R&D and external pharmaceutical partnerships. By integrating advanced computational chemistry with empirical structural data, the company aims to optimize lead compounds with high precision. The firm operates primarily as a technology-driven platform supporting the early stages of the drug development lifecycle in oncology and immunology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 上海西泰利生物医药科技.